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Background/Aims: The MedLey study investigated whether adhering to a
Mediterranean Diet (MedDiet) for 6 months would improve cardiometabolic
health and cognition.
Methods: A total of 152 Australians with a mean ± SD age of 71 ± 5 years
were randomly allocated to a habitual control diet (n¼ 72) or a MedDiet (n
¼ 80). Adherence was assessed using a 15-point score based on weighed
food records. Outcomes measured at 0, 3 and 6 months included lipids, C-
Reactive Protein, F2-isoprosanes, glucose, insulin, blood pressure, endo-
thelial function and cognition. Linear mixed models (intention to treat)
were used to compare groups over time.
Results: The MedDiet adherence score significantly increased from low to
high adherence at 6 months relative to the control which did not change (p
< 0.001). Plasma triglycerides were significantly lower at 3 (-0.149 ± 0.04
mmol/L; p < 0.001) and 6 months (-0.094 ± 0.04 mmol/L; p < 0.05). F2-
isoprostane concentrations were significantly lower at 3 (-107.6 ± 21.5
pmol/L; p < 0.001) and 6 months (-70.1 ± 22.1 pmol/L; p ¼ 0.013)
compared to the control. Compared to control, MedDiet had a greater
reduction in systolic blood pressure (p ¼ 0.02, for diet*time interaction):
-1.3 (95%CI: -2.2, -0.3) mmHg, p¼ 0.008 at 3 months, and -1.1 (95%CI: -2.0,
-0.1) mmHg, p ¼ 0.03 at 6 months. Endothelial function improved after 6
months (+1.27%) in the MedDiet relative to the control which did not
change (p ¼ 0.03). There was no difference between groups in cognitive
performance.
Conclusions:We’ve shown older Australians can follow the MedDiet for 6
months resulting in improvements in cardiovascular health whilst main-
taining cognitive function. This dietary pattern could be a feasible dietary
approach for improving heart health of Australians.
Funding source(s): NHMRC
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Background/Aims: Chronic diseases (CDs) have reached epidemic pro-
portions in Pacific Island countries. Unhealthy lifestyle is one of the major
risk factors and lifestyle interventions have been shown to be efficacious
for primary, secondary and early tertiary prevention. However, there is a
paucity of evidence regarding effective community-based lifestyle in-
terventions in the South Pacific (SP). This study examined the effectiveness
of a contextualised version of the evidence-based CHIP intervention, uti-
lising the low-literacy REFLECT approach.
Methods: A 30-day cluster-RCT of 48 adults with elevated risk (waist
circumference  92 cm for men and  80 cm for women), in two rural
Fijian villages was conducted. Intervention participants (n¼ 24) met three
times a week to receive the program. Control participants (n ¼ 24)
received only country-specific Ministry of Health literature. Outcome
assessments at baseline and 30 days included BMI, WC, blood pressure,
lipids and glucose. The extent of the change in each measures between
intervention and control villages was assessed using mixed between-
within ANOVA.
Results: In 30 days, significant reductions were recorded for intervention
participant’s BMI (2%), SBP (10%), DBP (8%), T-cholesterol (6%), LDL (12%),
HDL (15%) and blood glucose (10%), while triglycerides increased 35%. Only
DBP (7%) and T-cholesterol (8%) decreased in the control group.
Conclusions: This is the first lifestyle intervention using the REFLECT
approach to target CDs in the SP. Significant reductions in selected CD risk
factors were observed in 30 days, being comparable to cohorts in first
world countries. Larger scale research is warranted to assess broader de-
livery of this lifestyle intervention across the SP.
Funding source(s): N/A
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Background/Aims: The calcium binding protein S100B has been associ-
ated with significant health effects in humans. Elevated circulating levels
in later life cause neuronal apoptosis and brain inflammation, and has been
associated with severe and chronic pathology including Alzheimer’s dis-
ease. The potential benefits of plant extracts on health have become more
widely recognised and investigated. However, to date, their impact on
S100B levels are not well defined. The aim of this systematic review was to
identify candidate plant extracts and determine their effect on S100B
levels in animal pre-clinical trials.
Methods: The search strategy followed PRISMA 2009 guidelines, with four
electronic databases interrogated (PubMed, The Cochrane Library, Scopus
and CINAHL). Search terms were limited to “S100B” AND “Flavonoid”,
“Polyphenol”, “Plant Extract”. Only animal pre-clinical trials published in
English between 2000 and 2016 were included.
Results: In total, 12 journal articles were identified and 11 different plant
extracts were investigated: Green tea (EGCG), Resveratrol, Curcumin,
Bitter melon, Quercetin, Silymarin, Rutin, Saffron, Natto, Siberian Ginseng
and Cat’s claw. Several plant extracts indicated potential to reduce S100B
levels in in vivo animal models showing positive effects in brain neuro-
inflammation, epilepsy and restoration of blood-brain barrier dysfunction.
Conclusions: Plant extracts high in secondary plant metabolites have
shown significant beneficial effects in animal pre-clinical trials and as such
pose a stepping stone for development of potential nutraceuticals for use
in human trials.
Funding source(s): University of Canberra Health Research Institute
(UCHRI)
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Background/Aims: The physiology of the organism, such as age, sex and
disease status may influence biologic effects of an antioxidant. The effects
of chronic consumption of a moderate dose of HT-AC on oxidative stress
and inflammation inmale healthymice at different ages were investigated.
Methods: C57BL/6male mice (4 groups: young¼ 2 months age, old groups
¼ 17 months age, n ¼ 13 per group) were administered water solution
orally with or without HT-AC for 19 weeks. The dose of HT-AC supple-
mentation was 50 mg/kg body weight/d, given 5 times a week. Proin-
flammatory cytokines (IL-6, TNF-a and CRP) were assessed by ELISA. ROS
was detected by fluorescence. Formation of hepatic inflammatory foci was
examined. This study was approved by Experimental Animal Ethics
Committee of Northwestern Polytechnical University. Data were analysed
using 2 factor ANOVA.
Results: Young mice supplied with HT-AC had higher mean ± SD ROS
(194.92 ± 36.83 vs. 137.64 ± 36.56; p ¼ 0.0013), CRP (4.60 ± 0.91 vs. 3.09 ±
0.56; p ¼ 0.0005), IL-6 (43.73 ±1 3.40 vs. 24.24 ± 5.55; p ¼ 0.0001) and
TNF-a (60.67 ± 18.68 vs 33.85 ± 11.95; p ¼ 0.0006) in serum compared
with HT-AC-fed old mice. No significant changes of ROS, CRP, IL-6 and TNF-
a between old control and treatment groups were found, and the same
between young and old control groups. There was significant interaction
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